GUGGENHEIM CAPITAL LLC - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 165 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2021$564,000
+330.5%
23,601
+120.7%
0.00%
Q4 2016$131,000
+4.0%
10,694
+0.4%
0.00%
Q3 2016$126,000
+37.0%
10,655
-0.0%
0.00%
Q2 2016$92,000
+70.4%
10,658
+3.5%
0.00%
Q1 2016$54,000
-76.3%
10,300
-39.0%
0.00%
-100.0%
Q2 2014$228,000
+23.9%
16,884
-9.0%
0.00%0.0%
Q1 2014$184,000
-9.4%
18,544
+21.6%
0.00%0.0%
Q4 2013$203,000
+18.7%
15,245
+8.2%
0.00%0.0%
Q3 2013$171,000
+64.4%
14,090
+40.0%
0.00%
Q2 2013$104,00010,0640.00%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Casdin Capital, LLC 3,500,000$25,725,0003.13%
CADIAN CAPITAL MANAGEMENT, LP 3,830,399$28,153,0001.28%
Mesirow Financial Investment Management, Inc. 33,001$243,0001.25%
Bellevue Group AG 1,339,502$9,845,0000.62%
NEEDHAM INVESTMENT MANAGEMENT LLC 260,000$1,912,0000.58%
Lyon Street Capital, LLC 109,850$807,0000.50%
Private Wealth Partners, LLC 300,000$2,205,0000.34%
Penn Capital Management Company, LLC 455,064$3,345,0000.25%
HighTower Advisors, LLC 2,337,132$17,179,0000.12%
Schonfeld Strategic Advisors LLC 376,000$2,763,0000.12%
View complete list of GENMARK DIAGNOSTICS INC shareholders